Analysis of HER2 expression is important for monitoring treatment response and efficacy, particularly with regard to trastuzumab, a humanized monoclonal antibody that specifically binds to the HER2, inhibiting the growth of tumor cells and decreasing HER2 expression [23, 33, 34]. The gene discussed is ERBB2; the disease is neoplasm.